Literature DB >> 12776189

Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression.

Muriel D David1, Jacques Bertoglio, Josiane Pierre.   

Abstract

Interleukin (IL)-4 and IL-13 are two structurally and functionally related cytokines that have overlapping but also distinct biological activities. One of the components of the IL-13 receptor, the alpha2 chain (IL-13Ralpha2), has been reported to downregulate the cell responsiveness to IL-13, without affecting IL-4 signaling. Here, we report that TNFalpha synergizes with either IL-4 or IL-13 in inducing the IL-13Ralpha2 chain at both the mRNA and protein levels in the HaCaT human keratinocyte cell line. Further studies by 5'RACE identified as yet undescribed exonic sequences of the IL-13Ralpha2 5'UTR, provided evidence for the expression of alternatively spliced IL-13Ralpha2 transcripts and defined the transcription start of the IL-13Ralpha2 gene. A 1.5 kb region upstream of the first exon of the IL-13Ralpha2 gene displayed basal promoter activity when inserted in a reporter plasmid and transiently transfected in HaCaT cells. This promoter activity was further increased in response to IL-4 and IL-13. Furthermore, by electrophoretic mobility shift assay and site-directed mutagenesis, we showed that the IL-4/IL-13-induced promoter activity depended upon a positively acting STAT6 response element. Finally, TNFalpha was shown to potentiate IL-4/IL-13-induced IL-13Ralpha2 promoter activity when the same reporter construct was studied in stably but not in transiently transfected cells. These results suggest that the synergistic effect of TNFalpha on IL-4/IL-13-induced IL-13Ralpha2 expression is dependent upon chromatin re-modeling events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776189     DOI: 10.1038/sj.onc.1206352

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

2.  IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.

Authors:  Umasundari Sivaprasad; Manoj R Warrier; Aaron M Gibson; Weiguo Chen; Yasuhiro Tabata; Stacey A Bass; Marc E Rothenberg; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

3.  IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.

Authors:  Sara L Hall; Theresa Baker; Stephane Lajoie; Phoebe K Richgels; Yanfen Yang; Jaclyn W McAlees; Adelaide van Lier; Marsha Wills-Karp; Umasundari Sivaprasad; Thomas H Acciani; Timothy D LeCras; Jocelyn Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

4.  Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptor.

Authors:  Shannon D Whirledge; Christine M Jewell; Lisa M Barber; Xiaojiang Xu; Kevin S Katen; Stavros Garantziotis; John A Cidlowski
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

5.  Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models.

Authors:  Hideyuki Nakashima; Toshio Fujisawa; Syed R Husain; Raj K Puri
Journal:  J Transl Med       Date:  2010-11-10       Impact factor: 5.531

6.  IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Authors:  P P C Souza; A B Brechter; R I Reis; C A S Costa; P Lundberg; U H Lerner
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.

Authors:  Z Zhao; L Wang; W Xu
Journal:  Oncogene       Date:  2014-04-21       Impact factor: 9.867

8.  Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins.

Authors:  Yonghua Hao; Zhizhou Kuang; Jia Jing; Jinfeng Miao; Li Yu Mei; Ryan J Lee; Susie Kim; Shawn Choe; Duncan C Krause; Gee W Lau
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

Review 9.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

10.  A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects.

Authors:  M O'Toole; H Legault; R Ramsey; T A Wynn; M T Kasaian
Journal:  Clin Exp Allergy       Date:  2008-02-25       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.